Caseware UK (AP4) 2024.0.164 2024.0.164 Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312026-05-021271421555828013193810677360131938127142698630276519982026-05-02false2024-04-01No description of principal activity0172025-03-31 02970800 2024-04-01 2025-03-31 02970800 2023-04-01 2024-03-31 02970800 2025-03-31 02970800 2024-03-31 02970800 2024-04-01 02970800 2023-04-01 02970800 c:CompanySecretary1 2024-04-01 2025-03-31 02970800 c:RegisteredOffice 2024-04-01 2025-03-31 02970800 d:FurnitureFittings 2024-04-01 2025-03-31 02970800 d:FurnitureFittings 2025-03-31 02970800 d:FurnitureFittings 2024-03-31 02970800 d:CurrentFinancialInstruments 2025-03-31 02970800 d:CurrentFinancialInstruments 2024-03-31 02970800 c:FRS102 2024-04-01 2025-03-31 02970800 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 02970800 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 02970800 b:Trustee1 2024-04-01 2025-03-31 02970800 b:Trustee2 2024-04-01 2025-03-31 02970800 b:Trustee3 2024-04-01 2025-03-31 02970800 b:Trustee4 2024-04-01 2025-03-31 02970800 b:Trustee5 2024-04-01 2025-03-31 02970800 b:Trustee7 2024-04-01 2025-03-31 02970800 b:UnrestrictedFundsGeneral 2024-04-01 2025-03-31 02970800 b:RestrictedIncomeFunds 2024-04-01 2025-03-31 02970800 b:UnrestrictedFundsGeneral 2025-03-31 02970800 b:UnrestrictedFundsGeneral 2024-03-31 02970800 b:RestrictedIncomeFunds 2025-03-31 02970800 b:RestrictedIncomeFunds 2024-03-31 02970800 b:Activity1 2024-04-01 2025-03-31 02970800 b:FundraisingEvents b:Activity1 b:TotalUnrestrictedFunds 2024-04-01 2025-03-31 02970800 b:FundraisingEvents b:Activity1 2024-04-01 2025-03-31 02970800 b:FundraisingEvents b:Activity1 2023-04-01 2024-03-31 02970800 b:TotalUnrestrictedFunds 2025-03-31 02970800 b:TotalUnrestrictedFunds 2024-03-31 02970800 b:TotalRestrictedIncomeFunds 2025-03-31 02970800 b:TotalRestrictedIncomeFunds 2024-03-31 02970800 c:FullAccounts 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Registered number: 02970800
Charity number: 1041307











ARK MEDICAL TRUST
(A company limited by guarantee)








UNAUDITED

TRUSTEES' REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

 
ARK MEDICAL TRUST
 
(A company limited by guarantee)
 

CONTENTS



Page
Reference and administrative details of the Company, its Trustees and advisers
 
1
Trustees' report
 
2 - 5
Statement of financial activities
 
6
Balance sheet
 
7 - 8
Notes to the financial statements
 
9 - 23

 
ARK MEDICAL TRUST
 
(A company limited by guarantee)
 

REFERENCE AND ADMINISTRATIVE DETAILS OF THE COMPANY, ITS TRUSTEES AND ADVISERS
FOR THE YEAR ENDED 31 MARCH 2025


Trustees
  
C I O Brookes, Chairman
M Rees (deceased 26 November 2025)
M C D Roberts (resigned 12 November 2024)
D Newman
R G Finlayson
R E Walker

Company registered number

02970800

Charity registered number

1041307

Registered office

Victoria House39 Winchester StreetBasingstokeHampshireRG21 1EQ

Principal operating office

Ark CentreDinwoodie DriveBasingstokeHampshireRG24 9NN

Company secretary

R G Finlayson

Accountants

Shaw Gibbs LimitedWey Court WestUnion RoadFarnhamSurreyGU9 7PT

Bankers

Lloyds TSB Plc

Solicitors

Lamb Brooks LLPBasingstoke

Page 1

 
ARK MEDICAL TRUST
 
(A company limited by guarantee)
 
  
TRUSTEES' REPORT
FOR THE YEAR ENDED 31 MARCH 2025

The Trustees present their annual report together with the financial statements of the Company for the year 1 April 2024 to 31 March 2025The Annual report serves the purposes of both a Trustees' report and a directors' report under company law. The Trustees confirm that the Annual report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019). 
 

Since the Company qualifies as small under section 382 of the Companies Act 2006, the Strategic report required of medium and large companies under the Companies Act 2006 (Strategic Report and Directors' Report) Regulations 2013 has been omitted.
 

Objectives and activities
 

l Policies and objectives
 

The objectives of the Charity continue to be providing and advancing the study and general knowledge of science and medicine, surgery and dentistry which is achieved by the charity's wholly owned subsidiary which operates a conferencing and education facility with particular emphasis in the medical sector. We also offer sponsorship for the use of the ARK Centre by patient and other community groups.
 

In setting objectives and planning for activities, the Trustees have given due consideration to general guidance published by the Charity Commission relating to public benefit, including the guidance 'Public benefit: running a charity (PB2)'.
 

Achievements and performance
 

l Review of activities
 

Throughout the year, the Charity continued its support with providing a secure and uplifting environment for community groups, facilitating their activities without imposing significant financial burdens on their members, by funding room hire at the Ark Conference Centre. This support has been instrumental in enabling various community groups to meet over many years, collaborate, and share experiences.  Beneficiaries of our Community Support funding during the year, include Basingstoke Breast Care, Prostate PRISM, Look Good Feeling Better, Gynae Support Group, Focus Group, and the Endometriosis Group.
We express our gratitude to all those who have supported us, including our dedicated Trustees, Ark Employees and Community Partners. The Charity remains committed to ensuring that individuals and groups have access to a supportive environment for their activities.
 

Financial review
 

l Going concern
 

After making appropriate enquiries, the Trustees have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements.
 

Page 2

 
ARK MEDICAL TRUST
 
(A company limited by guarantee)
 
Financial review (continued)

l Reserves policy
 

It is the policy of the Charity to aim to build its free reserves to a level which equates to approximately a year's unrestricted expenditure. The trustees consider that this would provide sufficient funds to cover costs and to respond to any emergency needs, which may arise from time to time.
 

Structure, governance and management
 

l Constitution and Governing document
 

Ark Medical Trust is a Company Limited by Guarantee, not having Share Capital, and is governed by its Memorandum and Articles of Association dated 23rd September 1994. It is registered as a charity with the Charity Commission.
Charity number: 1041307
Company number: 02970800
The Charity currently has no members other than the Trustees each of whom agree to contribute no more than £1 in the event of the Charity winding up.
 

l Directors and Trustees
 

The directors of the charitable company ("the Charity") are its Trustees for the purpose of charity law and throughout this report are collectively referred to as "The Board". New Trustees are appointed at the discretion of the existing Trustees. Many of the Trustees have served a period of over 10 years. Due to their knowledge and the expertise they bring to the board we are delighted they have chosen to remain. There has been difficulty attracting new members to take their place.
As set out in the Articles of Association the Chairman of the Trustees is nominated by the Board.
At each Annual General Meeting one third of the members of the Board retire from office. Those members to retire are those who have been longest in office since their last election or appointment. A retiring member of the Board is eligible for re-election.
The Trustees report with sadness the death of Merv Rees on 26th November 2025. He was the driving force behind the fundraising that led to the building of the Ark Conference Centre and the numerous successful events held there.
 

l Trustee induction and training
 

New Trustees undergo orientation to brief them on their legal obligations under charity and company law, the content of the Memorandum and Articles of Association, the committee and decision making processes, the business plan and recent financial performance of the Charity. 
Trustees meet regularly at The Ark Conference Centre and are made aware of changes relating to the running of the Charity.
 

l Risk management
 

Risk Assessment Record is reviewed annually with detailed discussions taking place of any changes to the perceived exposure to certain areas of risk. The Conflict of Interest Register is also reviewed annually to reflect any changes.
 
Page 3

 
ARK MEDICAL TRUST
 
(A company limited by guarantee)
 
Structure, governance and management (continued)

 

Plans for future periods
 

Following Covid the popularity of online conferences and other events has meant that the trading subsidiary Ark Conference Centre Limited could no longer trade profitably and has had to close its activities.   The headlease from the hospital was has been surrendered back to the hospital in January 2026, and the Conference Centre will be run by the hospital and used, in accordance with the original objectives, for medical training. 
 

Statement of Trustees' responsibilities
 

The Trustees (who are also the directors of the Company for the purposes of company law) are responsible for preparing the Trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).


Company law requires the Trustees to prepare financial statements for each financial period. Under company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:

select suitable accounting policies and then apply them consistently;
observe the methods and principles of the Charities SORP (FRS 102);
make judgments and accounting estimates that are reasonable and prudent;
state whether applicable UK Accounting Standards (FRS 102) have been followed, subject to any material departures disclosed and explained in the financial statements;
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.


The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.


Members' liability
 

The Members of the Company guarantee to contribute an amount not exceeding £1 to the assets of the Company in the event of winding up.
 

Small companies
 

In preparing this report, the directors have taken advantage of the small companies exemptions provided by section 415A of the Companies Act 2006.
 

 

Approved by order of the members of the board of Trustees and signed on their behalf by:





C I O Brookes
(Chair of Trustees)
Page 4

 
ARK MEDICAL TRUST
 
(A company limited by guarantee)
 

Date: 2 May 2026

Page 5

 
ARK MEDICAL TRUST
 
(A company limited by guarantee)

 
 
STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT)
FOR THE YEAR ENDED 31 MARCH 2025


Unrestricted funds
2025
Restricted funds
2025
Total
funds
2025
Total
funds
2024
Note
        £
        £
        £
        £

Income from:







Donations and legacies

3

1,500

-

1,500

-
 
Other trading activities

4

3,600

-

3,600

-
 
Investments

5

-

2,398

2,398

88
 
Total income
5,100
2,398
7,498
88
Expenditure on:







Raising funds

6

18,157

-

18,157

8,779
 
Charitable activities

7

3,356

-

3,356

312
 
Total expenditure
21,513
-
21,513
9,091

Net (expenditure)/income before net losses on investments

  

(16,413)

2,398

(14,015)

(9,003)
 
Net losses on investments

  

(316,435)

-

(316,435)

(451,164)
 
Net movement in funds
  
(332,848)
2,398
(330,450)
(460,167)

Reconciliation of funds:

  





Total funds brought forward

  

3,825,999

63,571

3,889,570

4,349,737
 
Net movement in funds

  

(332,848)

2,398

(330,450)

(460,167)
 
Total funds carried forward
  
3,493,151
65,969
3,559,120
3,889,570

Page 6

 
ARK MEDICAL TRUST
 
(A company limited by guarantee)
REGISTERED NUMBER: 02970800

 
 
BALANCE SHEET
AS AT 31 MARCH 2025


2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 11 
12,870
12,870

Investments
 12 
3,456,302
3,772,737

Current assets
  

Debtors
 13 
16,879
29,239

Cash at bank and in hand
  
76,099
75,804

  
92,978
105,043

Creditors: amounts falling due within one year
 14 
(3,030)
(1,080)

Net current assets 
  
 
 
89,948
 
 
103,963

Total net assets 
  
3,559,120
3,889,570


Charity funds
  

Restricted funds
 15 
65,969
63,571

Unrestricted funds
 15 
3,493,151
3,825,999

Total funds
  
3,559,120
3,889,570

The Company was entitled to exemption from audit under section 477 of the Companies Act 2006.

The members have not required the company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006.

Page 7

 
ARK MEDICAL TRUST
 
(A company limited by guarantee)
REGISTERED NUMBER: 02970800

 
 
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2025

The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime.

The financial statements were approved and authorised for issue by the Trustees and signed on their behalf by:






C I O Brookes
(Chair of Trustees)

Date: 2 May 2026


The notes on pages 9 to 23 form part of these financial statements.

Page 8

 
ARK MEDICAL TRUST

(A company limited by guarantee)
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.


General information

Ark Medical Trust, is a private company limited by guarantee. The members of the Company are the Trustees named on page 1. In the event of the Company being wound up, the liability in respect of the guarantee is limited to £1 per member.
The Company is incorporated in England & Wales and its registered office address is Victoria House, 39 Winchester Street, Basingstoke, Hampshire, RG21 1EQ.


2.Accounting policies

  
2.1

Basis of preparation of financial statements

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

Ark Medical Trust meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.

  
2.2

Income

All income is recognised once the Company has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.

Grants are included in the Statement of financial activities on a receivable basis. The balance of income received for specific purposes but not expended during the period is shown in the relevant funds on the Balance sheet. Where income is received in advance of entitlement of receipt, its recognition is deferred and included in creditors as deferred income. Where entitlement occurs before income is received, the income is accrued.

Other income is recognised in the period in which it is receivable and to the extent the goods have been provided or on completion of the service.



Page 9

 
ARK MEDICAL TRUST

(A company limited by guarantee)
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

  
2.3

Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use.

Expenditure on raising funds includes all expenditure incurred by the Company to raise funds for its charitable purposes and includes costs of all fundraising activities events and non-charitable trading.

Expenditure on charitable activities is incurred on directly undertaking the activities which further the Company's objectives, as well as any associated support costs.

  
2.4

Interest receivable

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Company; this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited.

 
2.5

Tangible fixed assets and depreciation

Tangible fixed assets costing £250 or more are capitalised and recognised when future economic benefits are probable and the cost or value of the asset can be measured reliably. 

Tangible fixed assets are initially recognised at cost. After recognition, under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. All costs incurred to bring a tangible fixed asset into its intended working condition should be included in the measurement of cost.

A review for impairment of a fixed asset is carried out if events or changes in circumstances indicate that the carrying value of any fixed asset may not be recoverable. If such indication exists, the recoverable amount of the asset is determined to be the higher of its fair value less costs to sell and its value in use. An impairment loss is recognised where the carrying amount exceeds the recoverable amount.

Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Fixtures, fittings and equipment
-
5% - 50% straight line

Artwork is not depreciated.

Page 10

 
ARK MEDICAL TRUST

(A company limited by guarantee)
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

  
2.6

Investments

Investments in subsidiaries are valued at cost less provision for impairment.

  
2.7

Debtors

Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

  
2.8

Cash at bank and in hand

Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.


2.9

Liabilities and provisions

Liabilities are recognised when there is an obligation at the Balance sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.

Liabilities are recognised at the amount that the Company anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.

Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Statement of financial activities as a finance cost.

  
2.10

Financial instruments

The Company only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.

  
2.11

Fund accounting

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Company and which have not been designated for other purposes.

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Company for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.

Investment income, gains and losses are allocated to the appropriate fund.

Page 11

 
ARK MEDICAL TRUST

(A company limited by guarantee)
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

3.

Income from donations and legacies




Unrestricted funds
2025
Total
funds
2025
Total
funds
2024
        £
        £
        £
 


 
Donations

1,500

1,500

-
 


4.

Income from other trading activities

Income from fundraising events




Unrestricted funds
2025
Total
funds
2025
Total
funds
2024
        £
        £
        £




Charity dinner

3,600

3,600

-
 


5.

Investment income




Restricted funds
2025
Total
funds
2025
Total
funds
2024
        £
        £
        £




Interest receivable - restricted

2,398

2,398

88
 
Total 2024


88
88


Page 12

 
ARK MEDICAL TRUST

(A company limited by guarantee)
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

6.

Expenditure on raising funds

Costs of raising voluntary income




Unrestricted funds
2025
Total
funds
2025
Total
funds
2024
        £
        £
        £




Costs of raising funds

18,157

18,157

8,779
 
Total 2024


8,779
8,779









7.

Analysis of expenditure on charitable activities


Summary by fund type




Unrestricted funds
2025
Total
2025
Total
2024
        £
        £
        £




General fund

3,356

3,356

312
 
Total 2024


312
312


8.

Analysis of expenditure by activities




Support costs
2025
Total
funds
2025
Total
funds
2024
        £
        £
        £




General fund

3,356

3,356

312
 
Total 2024


312
312
Page 13

 
ARK MEDICAL TRUST

(A company limited by guarantee)
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

8.Analysis of expenditure by activities (continued)



Analysis of support costs




General teaching fund
2025
Total
funds
2025
Total
funds
2024
        £
        £
        £




Bank charges

192

192

182
 
Governance costs

3,164

3,164

130
 


3,356
3,356
312
Total 2024


312
312


9.



Staff costs





The average number of persons employed by the Company during the year was as follows:


2025
2024

No.
No.


Employees
-
17

The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was:


2025
2024

No.
No.


In the band £80,001 - £90,000
-
1

Page 14

 
ARK MEDICAL TRUST

(A company limited by guarantee)
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

10.


Trustees' remuneration and expenses

During the year, no Trustees received any remuneration or other benefits (2024 - £NIL).

During the year ended 31 March 2025, no Trustee expenses have been incurred (2024 - £NIL).


11.


Tangible fixed assets




Plant, machinery & fixtures

£


Cost or valuation

At 1 April 2024
13,350


At 31 March 2025

13,350


Depreciation

At 1 April 2024
480


At 31 March 2025

480


Net book value


At 31 March 2025
12,870


At 31 March 2024
12,870

Page 15

 
ARK MEDICAL TRUST

(A company limited by guarantee)
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

12.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation



At 1 April 2024
5,733,969



At 31 March 2025

5,733,969




Impairment



At 1 April 2024
1,961,232


Impairment on revaluation
316,435



At 31 March 2025

2,277,667




Net book value




At 31 March 2025
3,456,302



At 31 March 2024
3,772,737

Page 16

 
ARK MEDICAL TRUST

(A company limited by guarantee)
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

12.

Fixed asset investments (continued)

Principal subsidiaries

The following was a subsidiary undertaking of the Company:


Name

Company number

Registered office or principal place of business

Principal activity


The Ark Conference Centre Limited
03683701
Dinwoodie Drive, Basingstoke, Hampshire, RG24 9NN
Provision of a facility for conferencing and training in the field of medicine

Class of shares

Holding


Ordinary
100%

The financial results of the subsidiary for the year were:


Name

Income
£

Expenditure
£

Profit for the year
£


The Ark Conference Centre Limited
909,512
1,225,952
(316,440)

Net assets
£


3,456,302

13.



Debtors


2025
2024
£
£


Due within one year

Prepayments and accrued income
16,879
29,239

16,879
29,239


14.



Creditors: Amounts falling due within one year


Page 17

 
ARK MEDICAL TRUST

(A company limited by guarantee)
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
2025
2024
£
£


Accruals
3,030
1,080

Page 18

 
ARK MEDICAL TRUST

(A company limited by guarantee)
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

15.

Statement of funds


Statement of funds - current year

Balance at 1 April 2024
£
Income
£
Expenditure
£
Gains/
(Losses)
£
Balance at 31 March 2025
£

Unrestricted funds






Reserves

3,825,999

5,100

(21,513)

(316,435)

3,493,151
 

Restricted funds







Training fund

63,571

2,398

-

-

65,969
 

Total of funds


3,889,570
7,498
(21,513)
(316,435)
3,559,120

Page 19

 
ARK MEDICAL TRUST

(A company limited by guarantee)
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

15.

Statement of funds (continued)



Statement of funds - prior year

Balance at
1 April 2023
£
Income
£
Expenditure
£
Gains/
(Losses)
£
Balance at
31 March 2024
£

Unrestricted funds






Reserves

4,286,254

-

(9,091)

(451,164)

3,825,999
 


Restricted funds







Training fund

63,483

88

-

-

63,571
 


Total of funds


4,349,737
88
(9,091)
(451,164)
3,889,570


16.

Summary of funds


Summary of funds - current year

Balance at 1 April 2024
£
 
Income
£
 
Expenditure
£
 
Gains/
(Losses)
£
 
Balance at 31 March 2025
£
 
General funds

3,825,999

5,100

(21,513)

(316,435)

3,493,151
 
Restricted funds

63,571

2,398

-

-

65,969
 


3,889,570
7,498
(21,513)
(316,435)
3,559,120

Page 20

 
ARK MEDICAL TRUST

(A company limited by guarantee)
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

16.

Summary of funds (continued)


Summary of funds - prior year

Balance at
1 April 2023
£
 
Income
£
 
Expenditure
£
 
Gains/
(Losses)
£
 
Balance at
31 March 2024
£
 
General funds

4,286,254

-

(9,091)

(451,164)

3,825,999
 
Restricted funds

63,483

88

-

-

63,571
 


4,349,737
88
(9,091)
(451,164)
3,889,570

Training fund - An anonymous donation was given to the Trust, from an ex-patient of one of the Trustees to be used for the advancement of education.
 

Page 21

 
ARK MEDICAL TRUST

(A company limited by guarantee)
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

17.

Analysis of net assets between funds

Analysis of net assets between funds - current year

Unrestricted funds
2025
Restricted funds
2025
Total
funds
2025
        £
        £
        £



Tangible fixed assets

12,870

-

12,870

Fixed asset investments

3,456,302

-

3,456,302

Current assets

27,009

65,969

92,978

Creditors due within one year

(3,030)

-

(3,030)

Total 


3,493,151
65,969
3,559,120



Analysis of net assets between funds - prior year

Unrestricted funds
2024
Restricted funds
2024
Total
funds
2024
        £
        £
        £



Tangible fixed assets

12,870

-

12,870

Fixed asset investments

3,772,737

-

3,772,737

Current assets

41,472

63,571

105,043

Creditors due within one year

(1,080)

-

(1,080)

Total 

3,825,999
63,571
3,889,570

Page 22

 
ARK MEDICAL TRUST

(A company limited by guarantee)
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

18.


Free reserves

Free reserves are the amount of funds that the Charity holds at the end of the reporting period after making allowance for any restricted funds, designated funds and the carrying amount of fixed assets held.


2025
2024
£
£



Total reserves
3,559,120
3,889,570

Restricted reserves
(65,969)
(63,571)

Designated reserves
-
-

Net book value of fixed assets
(3,456,302)
(3,772,737)

36,849
53,262



19.


Related party transactions

During the year the Company incurred room hire charges on behalf of other organisations of £12,360 (2024: £8,400) from its subsidiary, The Ark Conference Centre Limited. At the year end the Company had prepaid for room hire totalling £16,879 (2024: £29,239).

Page 23